nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbamazepine—ABCC2—Rifampicin—leprosy	0.0866	0.101	CbGbCtD
Carbamazepine—CYP3A7—Rifampicin—leprosy	0.0578	0.0672	CbGbCtD
Carbamazepine—CYP3A7-CYP3A51P—Rifampicin—leprosy	0.0578	0.0672	CbGbCtD
Carbamazepine—CYP2B6—Rifampicin—leprosy	0.0551	0.064	CbGbCtD
Carbamazepine—CYP3A7—Dapsone—leprosy	0.0478	0.0555	CbGbCtD
Carbamazepine—CYP3A7-CYP3A51P—Dapsone—leprosy	0.0478	0.0555	CbGbCtD
Carbamazepine—CYP3A5—Thalidomide—leprosy	0.0448	0.052	CbGbCtD
Carbamazepine—CYP3A5—Rifampicin—leprosy	0.0434	0.0504	CbGbCtD
Carbamazepine—CYP2C8—Rifampicin—leprosy	0.0417	0.0485	CbGbCtD
Carbamazepine—CYP2C19—Thalidomide—leprosy	0.0361	0.042	CbGbCtD
Carbamazepine—CYP3A5—Dapsone—leprosy	0.0358	0.0416	CbGbCtD
Carbamazepine—CYP2C19—Rifampicin—leprosy	0.035	0.0407	CbGbCtD
Carbamazepine—CYP2C8—Dapsone—leprosy	0.0344	0.04	CbGbCtD
Carbamazepine—CYP1A2—Thalidomide—leprosy	0.0333	0.0387	CbGbCtD
Carbamazepine—CYP1A2—Rifampicin—leprosy	0.0323	0.0375	CbGbCtD
Carbamazepine—CYP2C9—Thalidomide—leprosy	0.03	0.0349	CbGbCtD
Carbamazepine—CYP2C9—Rifampicin—leprosy	0.0291	0.0338	CbGbCtD
Carbamazepine—CYP2C19—Dapsone—leprosy	0.0289	0.0336	CbGbCtD
Carbamazepine—ABCB1—Rifampicin—leprosy	0.0282	0.0328	CbGbCtD
Carbamazepine—CYP2C9—Dapsone—leprosy	0.024	0.0279	CbGbCtD
Carbamazepine—CYP3A4—Rifampicin—leprosy	0.0169	0.0197	CbGbCtD
Carbamazepine—Infertility male—Dapsone—leprosy	0.0145	0.104	CcSEcCtD
Carbamazepine—CYP3A4—Dapsone—leprosy	0.014	0.0162	CbGbCtD
Carbamazepine—Anaemia macrocytic—Thalidomide—leprosy	0.00683	0.0492	CcSEcCtD
Carbamazepine—Anaemia megaloblastic—Thalidomide—leprosy	0.00364	0.0262	CcSEcCtD
Carbamazepine—Suicide attempt—Dapsone—leprosy	0.00295	0.0212	CcSEcCtD
Carbamazepine—Thromboembolism—Thalidomide—leprosy	0.00269	0.0194	CcSEcCtD
Carbamazepine—Albuminuria—Dapsone—leprosy	0.00224	0.0161	CcSEcCtD
Carbamazepine—Meningitis—Thalidomide—leprosy	0.00221	0.0159	CcSEcCtD
Carbamazepine—Erythema nodosum—Thalidomide—leprosy	0.00198	0.0143	CcSEcCtD
Carbamazepine—Embolism venous—Thalidomide—leprosy	0.0017	0.0122	CcSEcCtD
Carbamazepine—Sexual dysfunction—Thalidomide—leprosy	0.00153	0.011	CcSEcCtD
Carbamazepine—Suicide attempt—Thalidomide—leprosy	0.00151	0.0109	CcSEcCtD
Carbamazepine—Embolism—Thalidomide—leprosy	0.00133	0.0096	CcSEcCtD
Carbamazepine—Galactorrhoea—Thalidomide—leprosy	0.00132	0.00951	CcSEcCtD
Carbamazepine—Neuralgia—Thalidomide—leprosy	0.00123	0.00887	CcSEcCtD
Carbamazepine—Cyanosis—Thalidomide—leprosy	0.00121	0.00871	CcSEcCtD
Carbamazepine—Nystagmus—Thalidomide—leprosy	0.0012	0.00863	CcSEcCtD
Carbamazepine—Psychotic disorder—Dapsone—leprosy	0.00119	0.00854	CcSEcCtD
Carbamazepine—Neuritis—Thalidomide—leprosy	0.00115	0.00826	CcSEcCtD
Carbamazepine—Albuminuria—Thalidomide—leprosy	0.00115	0.00826	CcSEcCtD
Carbamazepine—Amblyopia—Thalidomide—leprosy	0.00111	0.00798	CcSEcCtD
Carbamazepine—Muscular weakness—Dapsone—leprosy	0.00107	0.00771	CcSEcCtD
Carbamazepine—Endocrine disorder—Thalidomide—leprosy	0.00103	0.00744	CcSEcCtD
Carbamazepine—Pancreatitis—Dapsone—leprosy	0.00103	0.00741	CcSEcCtD
Carbamazepine—Blood disorder—Thalidomide—leprosy	0.00103	0.00738	CcSEcCtD
Carbamazepine—Accidental injury—Thalidomide—leprosy	0.000968	0.00697	CcSEcCtD
Carbamazepine—Photosensitivity reaction—Dapsone—leprosy	0.000958	0.0069	CcSEcCtD
Carbamazepine—Skin discolouration—Thalidomide—leprosy	0.000949	0.00683	CcSEcCtD
Carbamazepine—Bone disorder—Thalidomide—leprosy	0.000949	0.00683	CcSEcCtD
Carbamazepine—Thinking abnormal—Thalidomide—leprosy	0.000936	0.00673	CcSEcCtD
Carbamazepine—Oliguria—Thalidomide—leprosy	0.00093	0.00669	CcSEcCtD
Carbamazepine—Drug interaction—Thalidomide—leprosy	0.000924	0.00665	CcSEcCtD
Carbamazepine—Neuropathy peripheral—Dapsone—leprosy	0.000918	0.0066	CcSEcCtD
Carbamazepine—Leukocytosis—Thalidomide—leprosy	0.000912	0.00656	CcSEcCtD
Carbamazepine—Dyskinesia—Thalidomide—leprosy	0.000912	0.00656	CcSEcCtD
Carbamazepine—Hearing impaired—Thalidomide—leprosy	0.0009	0.00648	CcSEcCtD
Carbamazepine—Atrioventricular block—Thalidomide—leprosy	0.000883	0.00636	CcSEcCtD
Carbamazepine—Sinusitis—Dapsone—leprosy	0.000878	0.00632	CcSEcCtD
Carbamazepine—Coordination abnormal—Thalidomide—leprosy	0.000873	0.00628	CcSEcCtD
Carbamazepine—Pulmonary embolism—Thalidomide—leprosy	0.000857	0.00617	CcSEcCtD
Carbamazepine—Phosphatase alkaline increased—Thalidomide—leprosy	0.000857	0.00617	CcSEcCtD
Carbamazepine—Pharyngitis—Dapsone—leprosy	0.000834	0.006	CcSEcCtD
Carbamazepine—Depressed level of consciousness—Thalidomide—leprosy	0.000827	0.00595	CcSEcCtD
Carbamazepine—Colitis—Thalidomide—leprosy	0.000823	0.00592	CcSEcCtD
Carbamazepine—Blood urea increased—Thalidomide—leprosy	0.000809	0.00582	CcSEcCtD
Carbamazepine—Aplastic anaemia—Thalidomide—leprosy	0.000804	0.00579	CcSEcCtD
Carbamazepine—Cramps of lower extremities—Thalidomide—leprosy	0.000787	0.00566	CcSEcCtD
Carbamazepine—Tinnitus—Dapsone—leprosy	0.000784	0.00564	CcSEcCtD
Carbamazepine—Gynaecomastia—Thalidomide—leprosy	0.000767	0.00552	CcSEcCtD
Carbamazepine—Pulmonary oedema—Thalidomide—leprosy	0.000763	0.00549	CcSEcCtD
Carbamazepine—Hypertonia—Thalidomide—leprosy	0.000751	0.0054	CcSEcCtD
Carbamazepine—Hyperkinesia—Thalidomide—leprosy	0.000747	0.00538	CcSEcCtD
Carbamazepine—Mental disability—Thalidomide—leprosy	0.000744	0.00535	CcSEcCtD
Carbamazepine—Erythema—Dapsone—leprosy	0.000732	0.00526	CcSEcCtD
Carbamazepine—Lymphadenopathy—Thalidomide—leprosy	0.000729	0.00525	CcSEcCtD
Carbamazepine—Thrombophlebitis—Thalidomide—leprosy	0.000718	0.00517	CcSEcCtD
Carbamazepine—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.000715	0.00515	CcSEcCtD
Carbamazepine—Photosensitivity—Thalidomide—leprosy	0.000708	0.0051	CcSEcCtD
Carbamazepine—Vascular purpura—Thalidomide—leprosy	0.000695	0.005	CcSEcCtD
Carbamazepine—Deafness—Thalidomide—leprosy	0.000695	0.005	CcSEcCtD
Carbamazepine—Vision blurred—Dapsone—leprosy	0.00069	0.00496	CcSEcCtD
Carbamazepine—Cardiac failure congestive—Thalidomide—leprosy	0.000686	0.00494	CcSEcCtD
Carbamazepine—Injury—Thalidomide—leprosy	0.000677	0.00487	CcSEcCtD
Carbamazepine—Amnesia—Thalidomide—leprosy	0.000662	0.00476	CcSEcCtD
Carbamazepine—Dermatitis exfoliative—Thalidomide—leprosy	0.000659	0.00474	CcSEcCtD
Carbamazepine—Vertigo—Dapsone—leprosy	0.000657	0.00473	CcSEcCtD
Carbamazepine—Dermatitis bullous—Thalidomide—leprosy	0.000651	0.00468	CcSEcCtD
Carbamazepine—Purpura—Thalidomide—leprosy	0.000645	0.00464	CcSEcCtD
Carbamazepine—Cardiac failure—Thalidomide—leprosy	0.000637	0.00459	CcSEcCtD
Carbamazepine—Lethargy—Thalidomide—leprosy	0.000635	0.00457	CcSEcCtD
Carbamazepine—Hyponatraemia—Thalidomide—leprosy	0.000624	0.00449	CcSEcCtD
Carbamazepine—Osteoarthritis—Thalidomide—leprosy	0.000622	0.00448	CcSEcCtD
Carbamazepine—Diplopia—Thalidomide—leprosy	0.000622	0.00448	CcSEcCtD
Carbamazepine—Psychotic disorder—Thalidomide—leprosy	0.000607	0.00437	CcSEcCtD
Carbamazepine—Cardiac arrest—Thalidomide—leprosy	0.000591	0.00426	CcSEcCtD
Carbamazepine—Ataxia—Thalidomide—leprosy	0.000585	0.00421	CcSEcCtD
Carbamazepine—Tachycardia—Dapsone—leprosy	0.000583	0.00419	CcSEcCtD
Carbamazepine—Liver function test abnormal—Thalidomide—leprosy	0.000574	0.00413	CcSEcCtD
Carbamazepine—Orthostatic hypotension—Thalidomide—leprosy	0.000568	0.00409	CcSEcCtD
Carbamazepine—Hypokalaemia—Thalidomide—leprosy	0.000566	0.00407	CcSEcCtD
Carbamazepine—Toxic epidermal necrolysis—Thalidomide—leprosy	0.00056	0.00403	CcSEcCtD
Carbamazepine—Cramp muscle—Thalidomide—leprosy	0.00056	0.00403	CcSEcCtD
Carbamazepine—Muscular weakness—Thalidomide—leprosy	0.000549	0.00395	CcSEcCtD
Carbamazepine—Insomnia—Dapsone—leprosy	0.00054	0.00389	CcSEcCtD
Carbamazepine—Dysphagia—Thalidomide—leprosy	0.000538	0.00387	CcSEcCtD
Carbamazepine—Eosinophilia—Thalidomide—leprosy	0.000532	0.00383	CcSEcCtD
Carbamazepine—Pancreatitis—Thalidomide—leprosy	0.000527	0.00379	CcSEcCtD
Carbamazepine—Bronchitis—Thalidomide—leprosy	0.000517	0.00372	CcSEcCtD
Carbamazepine—Pancytopenia—Thalidomide—leprosy	0.000511	0.00367	CcSEcCtD
Carbamazepine—Pollakiuria—Thalidomide—leprosy	0.000497	0.00357	CcSEcCtD
Carbamazepine—Erectile dysfunction—Thalidomide—leprosy	0.000495	0.00356	CcSEcCtD
Carbamazepine—Photosensitivity reaction—Thalidomide—leprosy	0.000491	0.00353	CcSEcCtD
Carbamazepine—Weight increased—Thalidomide—leprosy	0.000489	0.00352	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Dapsone—leprosy	0.000488	0.00351	CcSEcCtD
Carbamazepine—Hyperglycaemia—Thalidomide—leprosy	0.000485	0.00349	CcSEcCtD
Carbamazepine—Pneumonia—Thalidomide—leprosy	0.000482	0.00347	CcSEcCtD
Carbamazepine—Infestation—Thalidomide—leprosy	0.000479	0.00345	CcSEcCtD
Carbamazepine—Drowsiness—Thalidomide—leprosy	0.000479	0.00345	CcSEcCtD
Carbamazepine—Infestation NOS—Thalidomide—leprosy	0.000479	0.00345	CcSEcCtD
Carbamazepine—Depression—Thalidomide—leprosy	0.000478	0.00344	CcSEcCtD
Carbamazepine—Stevens-Johnson syndrome—Thalidomide—leprosy	0.000475	0.00342	CcSEcCtD
Carbamazepine—Abdominal pain—Dapsone—leprosy	0.000472	0.0034	CcSEcCtD
Carbamazepine—Body temperature increased—Dapsone—leprosy	0.000472	0.0034	CcSEcCtD
Carbamazepine—Renal failure—Thalidomide—leprosy	0.000471	0.00339	CcSEcCtD
Carbamazepine—Neuropathy peripheral—Thalidomide—leprosy	0.00047	0.00338	CcSEcCtD
Carbamazepine—Stomatitis—Thalidomide—leprosy	0.000467	0.00336	CcSEcCtD
Carbamazepine—Conjunctivitis—Thalidomide—leprosy	0.000466	0.00335	CcSEcCtD
Carbamazepine—Haematuria—Thalidomide—leprosy	0.000457	0.00329	CcSEcCtD
Carbamazepine—Sinusitis—Thalidomide—leprosy	0.00045	0.00324	CcSEcCtD
Carbamazepine—Agranulocytosis—Thalidomide—leprosy	0.000447	0.00322	CcSEcCtD
Carbamazepine—Bradycardia—Thalidomide—leprosy	0.000438	0.00315	CcSEcCtD
Carbamazepine—Rhinitis—Thalidomide—leprosy	0.000431	0.0031	CcSEcCtD
Carbamazepine—Hepatitis—Thalidomide—leprosy	0.00043	0.0031	CcSEcCtD
Carbamazepine—Pharyngitis—Thalidomide—leprosy	0.000427	0.00307	CcSEcCtD
Carbamazepine—Urinary tract disorder—Thalidomide—leprosy	0.000425	0.00306	CcSEcCtD
Carbamazepine—Oedema peripheral—Thalidomide—leprosy	0.000424	0.00305	CcSEcCtD
Carbamazepine—Urethral disorder—Thalidomide—leprosy	0.000422	0.00304	CcSEcCtD
Carbamazepine—Erythema multiforme—Thalidomide—leprosy	0.000407	0.00293	CcSEcCtD
Carbamazepine—Eye disorder—Thalidomide—leprosy	0.000402	0.00289	CcSEcCtD
Carbamazepine—Tinnitus—Thalidomide—leprosy	0.000401	0.00289	CcSEcCtD
Carbamazepine—Cardiac disorder—Thalidomide—leprosy	0.000399	0.00287	CcSEcCtD
Carbamazepine—Angiopathy—Thalidomide—leprosy	0.00039	0.00281	CcSEcCtD
Carbamazepine—Immune system disorder—Thalidomide—leprosy	0.000389	0.0028	CcSEcCtD
Carbamazepine—Mediastinal disorder—Thalidomide—leprosy	0.000388	0.00279	CcSEcCtD
Carbamazepine—Chills—Thalidomide—leprosy	0.000386	0.00278	CcSEcCtD
Carbamazepine—Arrhythmia—Thalidomide—leprosy	0.000384	0.00277	CcSEcCtD
Carbamazepine—Alopecia—Thalidomide—leprosy	0.00038	0.00274	CcSEcCtD
Carbamazepine—Vomiting—Dapsone—leprosy	0.00038	0.00273	CcSEcCtD
Carbamazepine—Mental disorder—Thalidomide—leprosy	0.000377	0.00271	CcSEcCtD
Carbamazepine—Malnutrition—Thalidomide—leprosy	0.000375	0.0027	CcSEcCtD
Carbamazepine—Headache—Dapsone—leprosy	0.000374	0.00269	CcSEcCtD
Carbamazepine—Tension—Thalidomide—leprosy	0.000368	0.00264	CcSEcCtD
Carbamazepine—Dysgeusia—Thalidomide—leprosy	0.000367	0.00264	CcSEcCtD
Carbamazepine—Nervousness—Thalidomide—leprosy	0.000364	0.00262	CcSEcCtD
Carbamazepine—Back pain—Thalidomide—leprosy	0.000362	0.00261	CcSEcCtD
Carbamazepine—Muscle spasms—Thalidomide—leprosy	0.00036	0.00259	CcSEcCtD
Carbamazepine—Nausea—Dapsone—leprosy	0.000355	0.00255	CcSEcCtD
Carbamazepine—Vision blurred—Thalidomide—leprosy	0.000353	0.00254	CcSEcCtD
Carbamazepine—Tremor—Thalidomide—leprosy	0.000351	0.00253	CcSEcCtD
Carbamazepine—Anaemia—Thalidomide—leprosy	0.000346	0.00249	CcSEcCtD
Carbamazepine—Agitation—Thalidomide—leprosy	0.000344	0.00248	CcSEcCtD
Carbamazepine—Angioedema—Thalidomide—leprosy	0.000342	0.00246	CcSEcCtD
Carbamazepine—Vertigo—Thalidomide—leprosy	0.000337	0.00242	CcSEcCtD
Carbamazepine—Syncope—Thalidomide—leprosy	0.000336	0.00242	CcSEcCtD
Carbamazepine—Leukopenia—Thalidomide—leprosy	0.000335	0.00241	CcSEcCtD
Carbamazepine—Loss of consciousness—Thalidomide—leprosy	0.000329	0.00237	CcSEcCtD
Carbamazepine—Convulsion—Thalidomide—leprosy	0.000325	0.00234	CcSEcCtD
Carbamazepine—Hypertension—Thalidomide—leprosy	0.000323	0.00233	CcSEcCtD
Carbamazepine—Chest pain—Thalidomide—leprosy	0.000319	0.00229	CcSEcCtD
Carbamazepine—Myalgia—Thalidomide—leprosy	0.000319	0.00229	CcSEcCtD
Carbamazepine—Arthralgia—Thalidomide—leprosy	0.000319	0.00229	CcSEcCtD
Carbamazepine—Anxiety—Thalidomide—leprosy	0.000318	0.00229	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000317	0.00228	CcSEcCtD
Carbamazepine—Dry mouth—Thalidomide—leprosy	0.000312	0.00224	CcSEcCtD
Carbamazepine—Confusional state—Thalidomide—leprosy	0.000308	0.00222	CcSEcCtD
Carbamazepine—Oedema—Thalidomide—leprosy	0.000306	0.0022	CcSEcCtD
Carbamazepine—Infection—Thalidomide—leprosy	0.000304	0.00219	CcSEcCtD
Carbamazepine—Shock—Thalidomide—leprosy	0.000301	0.00216	CcSEcCtD
Carbamazepine—Nervous system disorder—Thalidomide—leprosy	0.0003	0.00216	CcSEcCtD
Carbamazepine—Thrombocytopenia—Thalidomide—leprosy	0.000299	0.00215	CcSEcCtD
Carbamazepine—Tachycardia—Thalidomide—leprosy	0.000298	0.00215	CcSEcCtD
Carbamazepine—Skin disorder—Thalidomide—leprosy	0.000297	0.00214	CcSEcCtD
Carbamazepine—Hyperhidrosis—Thalidomide—leprosy	0.000296	0.00213	CcSEcCtD
Carbamazepine—Anorexia—Thalidomide—leprosy	0.000291	0.0021	CcSEcCtD
Carbamazepine—Hypotension—Thalidomide—leprosy	0.000286	0.00206	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Thalidomide—leprosy	0.000279	0.002	CcSEcCtD
Carbamazepine—Insomnia—Thalidomide—leprosy	0.000276	0.00199	CcSEcCtD
Carbamazepine—Paraesthesia—Thalidomide—leprosy	0.000274	0.00198	CcSEcCtD
Carbamazepine—Dyspnoea—Thalidomide—leprosy	0.000273	0.00196	CcSEcCtD
Carbamazepine—Somnolence—Thalidomide—leprosy	0.000272	0.00196	CcSEcCtD
Carbamazepine—Dyspepsia—Thalidomide—leprosy	0.000269	0.00194	CcSEcCtD
Carbamazepine—Decreased appetite—Thalidomide—leprosy	0.000266	0.00191	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Thalidomide—leprosy	0.000264	0.0019	CcSEcCtD
Carbamazepine—Fatigue—Thalidomide—leprosy	0.000264	0.0019	CcSEcCtD
Carbamazepine—Constipation—Thalidomide—leprosy	0.000261	0.00188	CcSEcCtD
Carbamazepine—Pain—Thalidomide—leprosy	0.000261	0.00188	CcSEcCtD
Carbamazepine—Feeling abnormal—Thalidomide—leprosy	0.000252	0.00181	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Thalidomide—leprosy	0.00025	0.0018	CcSEcCtD
Carbamazepine—Urticaria—Thalidomide—leprosy	0.000243	0.00175	CcSEcCtD
Carbamazepine—Body temperature increased—Thalidomide—leprosy	0.000242	0.00174	CcSEcCtD
Carbamazepine—Abdominal pain—Thalidomide—leprosy	0.000242	0.00174	CcSEcCtD
Carbamazepine—Hypersensitivity—Thalidomide—leprosy	0.000225	0.00162	CcSEcCtD
Carbamazepine—Asthenia—Thalidomide—leprosy	0.000219	0.00158	CcSEcCtD
Carbamazepine—Pruritus—Thalidomide—leprosy	0.000216	0.00156	CcSEcCtD
Carbamazepine—Diarrhoea—Thalidomide—leprosy	0.000209	0.00151	CcSEcCtD
Carbamazepine—Dizziness—Thalidomide—leprosy	0.000202	0.00145	CcSEcCtD
Carbamazepine—Vomiting—Thalidomide—leprosy	0.000194	0.0014	CcSEcCtD
Carbamazepine—Rash—Thalidomide—leprosy	0.000193	0.00139	CcSEcCtD
Carbamazepine—Dermatitis—Thalidomide—leprosy	0.000193	0.00139	CcSEcCtD
Carbamazepine—Headache—Thalidomide—leprosy	0.000192	0.00138	CcSEcCtD
Carbamazepine—Nausea—Thalidomide—leprosy	0.000182	0.00131	CcSEcCtD
